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Abstract
An R0 margin width of 1 cm has traditionally been considered a prerequisite to minimize local recurrence
and optimize survival following hepatic resection for metastatic colorectal cancer. However, recent data
have called into question the prognostic importance of the ‘1-cm rule’. Specifically, several studies have
noted that, although an R0 resection is important, the actual margin width may not be as critical. We
provide a brief overview of the impact of an R1 vs. an R0 resection on local recurrence and overall survival.
In addition, we specifically review the impact of margin width in patients who have undergone an R0
resection. Finally, we highlight those factors most associated with an increased likelihood of an R1
resection and provide recommendations for avoiding and dealing with microscopic carcinoma discovered
intraoperatively at the cut parenchymal transection margin.
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Introduction
Hepatic resection is the most effective therapy for patients with
colorectal liver metastases (CLM) confined to the liver, with
reported actuarial survival rates approaching 58% at 5 years,1–3
and 22–26% at 10 years.1,4–6 Several preoperative clinicopathologi-
cal factors have traditionally been utilized to identify the patients
who might benefit most from liver resection. These include size
and number of liver tumours, primary tumour nodal status,
length of disease-free interval and pre-resection carcinoembry-
onic antigen (CEA) level.5,7 Although they are predictive of prog-
nosis and indicative of tumour biology, these factors are fixed and
are outside the direct control of the surgeon. By contrast, the
status of the resection margin is one of the few modifiable factors
that have been investigated as being of prognostic importance.
Although the adverse impact of leaving gross residual disease at
the time of resection (R2) has been well documented, the prog-
nostic implications of a microscopically positive surgical margin
(R1) and of the width of a microscopically negative surgical
margin (R0) remain controversial.
Despite the lack of extensive evidence, since the early 1980s
there had been a general consensus that the optimal surgical
margin during resection of CLM should measure 1 cm. In fact,
some authors even suggested that inability to accommodate a
1-cm margin should perhaps preclude a patient from being con-
sidered for hepatic resection.8–10 Despite small patient numbers,
these initial reports led to a de facto acceptance of a ‘1-cm rule’
with regard to the margin, which was utilized to guide the selec-
tion of patients for hepatic resection. More recently, however,
multiple reports have questioned whether margin width has any
effect on outcome as long as a negative margin is achieved.3,11–15 In
fact, pathological studies from Japan have suggested that that the
1-cm rule should be completely abandoned, as micrometastases,
satellitosis and Glisson sheath extension associated with CLM are
exceptionally rare.16,17 Perhaps even more controversial, de Haas
and colleagues recently reported similar overall survival rates fol-
lowing margin-negative (R0) and margin-positive (R1) hepatec-
tomy for CLM using an aggressive approach combining
chemotherapy and repeat surgery.18 To complicate the matter
further, accurate assessment of margin status can sometimes be
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difficult as the techniques used to transect the parenchyma may
vaporize, aspirate, ablate or fracture the tissue on the parenchyma
edge, thereby leading to an overestimation of the resection
margin.
We herein present a brief overview of the current existing lit-
erature on the topic of surgical resection margin status. Specifi-
cally, we assess the impact of a positive (R1) margin, as well as the
impact of a sub-centimetre R0 resection margin on both survival
and recurrence following resection of CLM.
Microscopically positive R1 margin status
Multiple studies on the resection of CLM have specifically exam-
ined the role of a microscopically positive margin on overall
survival.1,3,5,8,18–20 With the exception of one recent report,18 all
previous studies (Table 1) have demonstrated consistently that a
microscopically positive R1 margin is strongly correlated with
worse overall survival. Specifically, 5-year survival following a
microscopically negative R0 resection has been reported to range
from 37% to 64%, whereas 5-year survival rates after an R1 resec-
tion are less than 20%. Interestingly, the data on whether R1
margin status is an independent predictor of overall survival have
been conflicting. Although several trials1,5,8 have found R1 margin
status to be associated with survival onmultivariate analysis, other
studies3,18,19 have noted that R1 margin status was not associated
with survival after controlling for competing risk factors. Because
of the lack of association of R1 status with survival onmultivariate
analysis, some investigators have suggested that, rather than being
an independent predictor of survival, R1 margin status may
instead be a surrogate indicator of advanced and/or more exten-
sive disease. As such, the negative impact of R1 status on overall
survival may not derive from the leaving of microscopic tumour
cells at the surgical margin, but, rather, from the more aggressive
biological phenotype that makes extirpation of the tumour with
negative surgical margins more difficult.
Recently, de Haas and colleagues18 published a provocative
study reporting that patients undergoing R1 vs. R0 resection had
comparable longterm survival outcomes. In this study, 436
patients with CLM were treated with combined modality therapy
utilizing modern cytotoxic chemotherapy and surgical resection;
mean follow-up was 40 months. The authors noted that CEA
>10 ng/ml and receipt of major hepatectomy, but not R1 margin
status, were independent predictors of poor overall survival.18
Unlike in many previous studies, 5-year overall survival rates were
similar between patients who had undergone an R0 vs. an R1
resection (61% vs. 57%, respectively). The study has been criti-
cized for its unusually high incidence of R1 resection (46%),
which may have resulted in part from the aggressive surgical
approach adopted by the investigators. Although the results of this
study need to be corroborated, the data provide further evidence
that R1 status may not be the main determinant of overall sur-
vival. Rather, it may be that emerging, more efficacious chemo-
therapy will provide patients who undergo an R1 resection with
worse associated tumour biology better longterm outcomes.
R1 surgical resection margin status has also been strongly asso-
ciated with an increased risk of both true margin (e.g. cut paren-
chymal transection edge) as well as ‘any-site’ intrahepatic
recurrence (Table 2).3,8,16,18,19,21,22 Whereas local recurrence at the
surgical margin has been reported to occur in only 3–8% of cases
following an R0 resection, the rate of local recurrence has been
noted to be as high as 9–55% following an R1 resection.3,16,18,19,22
The largest series to address the specific issue of margin status and
local recurrence investigated 557 patients from three major hepa-
tobiliary centres. The authors reported that CEA >200 ng/ml,
tumour size >5 cm and R1 margin status were each associated
with a higher overall recurrence rate, but only R1 margin status
predicted true margin recurrence.3 Similarly, any-site recurrence
in the liver has also been reported to be higher following an R1
resection (22–78%) compared with an R0 resection (14–
38%).3,8,18,19,21 In a study of 436 patients at Hôpital Paul-Brousse in
Table 1 Reported differences in overall survival based on margin status (R0 vs. R1 resection) after hepatic resection for colorectal liver
metastases
Author(s) Year n Study period Follow-up,
months
R1 rate Survival
5-year Median, months P-value
R0 R1 R0 R1
Steele et al.20 1991 87 1984–1988 37 21% – – 37 21 <0.01
Cady et al.8 1998 244 – 37 16% – – 18a 9a <0.05b
Fong et al.5 1999 1001 1985–1998 – 11% 37% 20% 45 23 <0.001b
Choti et al.1 2002 226 1984–1999 – 5% – – 46 24 0.04b
Pawlik et al.3 2005 557 1990–2004 29 8% 64% 17% NR 49 0.01
Nuzzo et al.19 2008 185 1992–2005 39 5% 39% 0% 48 22 0.01
de Haas et al.18 2008 436 1990–2006 40 46% 61% 57% 77 84 0.27
aIndicates disease-free survival
bP remained significant (<0.05) on multivariate analysis
P-values shown in bold indicate <0.05
NR, not reached
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France, any-site intrahepatic recurrence was significantly higher
following R1 resection.18 The finding that R1 margin status
increased the risk of discontiguous any-site recurrence again
implies that patients who undergo an R1 resection may have more
extensive liver disease and perhaps an inherently worse overall
biology that predisposes them to intrahepatic recurrence.
Cumulative data from the literature would strongly suggest that
an R1 margin status is associated with worse overall longterm
survival, as well as an increased risk of margin site and intrahe-
patic recurrence. Although true margin recurrence may be asso-
ciated with residual microscopic disease at the cut parenchymal
edge, the worse overall survival and increased rate of any-site
intrahepatic recurrence may reflect a worse tumour biology in
patients with more extensive disease in whom it is more difficult
to achieve an R0 margin. The fact remains, however, that surgeons
should strive assiduously to achieve complete macro- and micro-
scopic resection of CLM to help ensure the best overall and local
outcomes for the patient.
Microscopically negative R0 margin status: is
there an optimal margin width?
Although surgeons strive to achieve a complete resection with
negative margins during hepatectomy for CLM, the ideal margin
width to optimize longterm survival and minimize local recur-
rence has been the subject of considerable debate. In the mid-
1980s, Ekberg et al. reported a series of 72 resected patients. In this
series, the authors noted poor outcomes associated with sub-
centimetre resections and therefore concluded that liver resection
for CLM should not be performed if a margin1 cm could not be
anticipated.9 Although other studies have noted similar findings
with regard to the 1-cm rule,8,10,22–24 these studies had several limi-
tations, including small sample sizes, lack of multivariate analysis,
or the inappropriate inclusion of patients with positive margins in
the sub-centimetre margin category.More recently, emerging con-
temporary data from several institutions have begun to call the
1-cm rule into serious question. For example, Are et al.25 and Elias
et al.26 demonstrated that, although a 1-cm margin should be
attempted whenever possible, sub-centimetre resections were also
associated with favourable outcomes and should not preclude
patients from undergoing resection. In two separate studies,
Kokudo et al.16 and Nuzzo et al.19 proposed that margin widths of
2 mm and 5 mm, respectively, were acceptable and led to similar
outcomes compared with 1-cm margin resections. More recently,
a considerable body of literature3,11–15 has emerged which strongly
suggests that survival following hepatic resection for CLM is
similar among patients who have undergone an R0 resection,
regardless of the width of the negative margin. These investigators
note that complete R0 resection – not millimetres of margin width
– determines the outcome.27
In a multi-institutional study of 557 patients, Pawlik et al.3
reported similar outcomes in patients with negative margins,
regardless of margin width (Fig. 1). Specifically, after hepatic
resection, 225 (40.4%) patients had recurrence. This recurrence
was seen at the surgical margin in 21 patients, at another intrahe-
patic site in 56, at an extrahepatic site in 82, and at both intrahe-
patic and extrahepatic sites in 66. Patients with negative margins
of 1–4 mm, 5–9 mm and 1 cm had similar rates of true margin
recurrence, as well as overall recurrence. In addition, overall sur-
vival among patients undergoing an R0 resection was similar,
regardless of the width of the surgical margin. The authors con-
cluded that the width of a negative surgical margin does not affect
survival, recurrence risk or site of recurrence. A predicted margin
of <1 cm after resection of hepatic CLM should not be used as an
exclusion criterion for resection.
In a separate study from the Memorial Sloan–Kettering Cancer
Center, Are et al. reported on 1019 patients who underwent resec-
tion with a uniform method of parenchymal transection (Kelly
clamp-crush technique).25 The authors reported an R1 resection
rate of 11%; 33% of patients had an R0 margin >10 mm, whereas
56% of patients had an R0 margin of 10 mm. When margin
width was examined as a continuous variable, an incremental
Table 2 Reported differences in marginal and overall intrahepatic recurrence based on margin status (R0 vs. R1 resection) after hepatic
resection for colorectal metastases




R0 R1 P-value R0 R1 P-value
Hughes et al.21 1986 607 – – 6% – – – 38% 68% <0.05b
Cady et al.8 1998 244 – 37 16% – – – 23% 43% 0.03
Kokudo et al.16 2002 183 1980–2000 29 25%a 6% 20% – – – –
Pawlik et al.3 2005 557 1990–2004 29 8% 3% 11% 0.003 14% 22% –
Wakai et al.22 2008 90 1989–2004 – 11% 3% 30% 0.001b – – –
Nuzzo et al.19 2008 185 1992–2005 39 5% 4% 55% <0.01 27% 78% <0.01
de Haas et al.18 2008 436 1990–2006 40 46% 8% 9% 0.72 17% 28% 0.004
aR1 resection was defined in this study as margin clearance <2 mm
bP remained significant (<0.05) on multivariate analysis
P-values shown in bold indicate <0.05
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increase in median survival was shown as margin width increased,
with two inflection points on the curve: one at approximately
0 mm and one at 10 mm (Fig. 2). On the basis of this analysis, the
authors subsequently stratified patients into three groups (R1
margin, R0 margin of 1–10 mm, R0 margin >10 mm). On multi-
variate analysis, patients with a margin of >10 mm had better
longterm survival compared with patients with an R0 resection
with a margin of <10 mm. However, of note was the finding of no
difference in survival among patients with a <10-mm margin,
regardless of the width of the sub-centimetre margin. In fact,
among patients with a sub-centimetre R0 margin, longterm sur-
vival was quite favourable, with a median survival of 42 months.
As such, the authors concluded that failure to anticipate a 1-cm
margin as a result of anatomic constraints or by misjudgement of
the actual margin based on preoperative imaging should not pre-
clude a patient from undergoing resection.
Other studies have further corroborated that a margin width of
<1 cm is acceptable as it does not necessarily lead to a worse local
or overall outcome. In a study of 523 patients who had undergone
R0 resection, Figueras et al.11 reported that the existence of more
than three tumours and the presence of extrahepatic disease, but
not margin width of <1 cm, were independently associated with
hepatic recurrence. Similarly, Scheele et al.15 reported on 350
patients who underwent R0 resection. On multivariate analysis,
factors including synchronous presentation, primary tumour
lymph node status, poor tumour differentiation, presence of sat-
ellite lesions, and the number and size of the liver metastasis were
each associated with a worse outcome. A margin width of <1 cm
was, however, not associated with an adverse outcome. These data
strongly suggest that biology, rather than millimetres, dictates
outcome following resection of CLM.
Several studies from Japan have begun to provide molecular
clues into the issue of margin width and CLM resection.16,17
Kokudo and colleagues examined specimens from 58 patients who
underwent hepatic resection of CLM for K-ras and p53mutations.
In this study, the authors noted that micro-metastases adjacent to
the index CLMwere very uncommon, occurring in only 2% of 199
tested tumours. In addition, in the 2% of tumours that showed
evidence of micro-metastatic disease adjacent to the index lesion,
all were confined towithin 4 mmof the tumour border.16Although
micrometastases along the Glisson pedicle were somewhat more
common (14%), these were also confined within a short distance
from the tumour edge (<5 mm).16 In a separate study, Yamamoto
et al. analysed 89 CLM lesions resected from 40 patients.17 These
authors noted that all the lesions were well circumscribed and that
satellitosis was present in only one tumour.17 Taken together, these
data strongly suggest that aggressive biological factors, and not
necessarilymarginwidth, dictate outcome following hepatic resec-
tion of CLM. Although achieving an R0 surgical margin remains
important, the actual surgical margin width may not be as critical.
Surgeons should strive to perform resections with a margin of
non-tumorous liver tissue, but a predictedmargin of <1 cm should
not be used as a contraindication for resection. Rather, the
currently available data support the concept of limited complete
resection, utilizing a planned approach that encompasses all
tumour-bearing hepatic parenchyma.27
Planning the hepatic resection: avoidance of
the R1 margin
The presence of multiple tumours and bilateral distribution are























Figure 1 Survival stratified by margin status in 557 patients who
underwent liver resection for colorectal metastases. The width of
margin clearance did not affect survival as long as the margin was
negative. Reproduced with permission from Pawlik et al.3
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Group 3 (>10 mm)
Figure 2 Influence of margin width (analysed as a continuous vari-
able) on survival in 1019 patients who underwent hepatic resection
for metastatic colorectal cancer. Based on the two inflection points
noted on the curve at approximately 0 mm and 10 mm, patients
were stratified into three groups (involved margin, 1–10 mm and
>10 mm). Reproduced with permission from Are et al.25
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R1 resection.3,11,18,19,25,26 In addition, large tumours18 and tumours
located centrally or in proximity to a major vessel24 have also been
shown to be more difficult to extirpate with negative surgical
margins.
In an attempt to increase the chance of an R0 resection, some
investigators have advocated the use of neoadjuvant chemo-
therapy.28 The University of Texas MD Anderson Cancer Center
reported on a series of 108 patients who underwent hepatectomy,
61 of whom had received preoperative chemotherapy. The authors
reported that those patients who received preoperative chemo-
therapy had a significantly higher incidence of multiple tumours.
Despite this, patients who had received preoperative chemo-
therapy had a higher rate of R0 resection compared with those
who did not, although the difference failed to reach statistical
significance.28 In a separate study fromMemorial Sloan–Kettering
Cancer Center, the use of preoperative chemotherapy was not
associated with an increased rate of R0 resection with >1 cm
margin width.25 Therefore, although the administration of sys-
temic chemotherapy prior to liver resection for CLM may some-
times allow for a more parenchyma-sparing procedure, there is no
definitive evidence that it necessarily leads to an increase in the
likelihood of R0 surgical margins. In fact, recent data on the
pathological pattern of CLM response to chemotherapy have sug-
gested that, in addition to the dominant pattern of centripetal
tumour contraction, regional differences in chemosensitivity
within a single metastasis can lead to random tumour cell death
throughout the tumour and the persistence of islands of viable
tumour cells outside the edge of the contracted tumour.29 Such
data may provide a potential explanation for the comparable R1
margin rates following resection of CLM irrespective of the use of
preoperative chemotherapy.
As well as preoperative tumour-related features, intraoperative
technical factors may be associated with a higher likelihood of an
R1margin status.Although some studies have suggested that non-
anatomic resections24,30 may be associated with an increased risk
of R1 resection, other investigators have found this not to be the
case.31 Based on a retrospective series of 267 patients who under-
went liver resection for CLM, DeMatteo et al. reported that ana-
tomic segmental resection had a lower rate of positive margins
compared with wedge hepatectomy (2% vs. 16%, respectively).30
However, in a separate study, Zorzi et al. reported that anatomic
resection was not superior to non-anatomic resection in terms of
surgical margin clearance, site of recurrence or survival.31 In this
study, the authors concluded that resection with a clear surgical
margin – irrespective of whether an anatomic or non-anatomic
resection is performed – leads to the same acceptable outcome.
In addition, the technique of parenchymal transection does not
appear to influence the likelihood of an R1 resection. In a pro-
spective randomized trial of 132 patients undergoing partial hepa-
tectomy for primary and metastatic liver cancer, Takayama et al.
compared parenchymal transection utilizing the clamp-crush
technique with ultrasonic dissection.32 The authors noted no sig-
nificant difference in the incidence of margin recurrence between
the two techniques.32 Other authors have also noted that the
addition of saline-linked cautery to ultrasonic dissection does not
decrease the likelihood of an R1 resection.33
Occasionally, following resection a positive margin is recog-
nized intraoperatively. When gross residual disease remains (R2
resection), re-resection of the area should be undertaken because
leaving gross residual disease behind should be avoided in all
circumstances. If microscopic carcinoma is noted at the parenchy-
mal transection margin based on intraoperative frozen section
analysis, strategies to extend the resection margin are reasonable,
but their benefit remains unproven. Fastidious intraoperative ori-
entation andmarking of the specimen for pathological assessment
is critical at the time the specimen is removed. Close attention to
the area along the transection line, which is worrisome for a close
margin, can help direct where to re-treat the liver edge if the
margin proves to be microscopically positive for carcinoma. In the
study by Pawlik et al.3 different techniques were used to treat
positive margins at the time of resection.When additional surgical
resection was not feasible, ablation with radiofrequency or cautery
was used to treat the positive margin. We currently prefer to
re-resect or, when this is not feasible, to use saline-linked cautery
to treat positive margins. Animal data have suggested that saline-
linked surface radiofrequency ablation can achieve destruction of
1 cm of hepatic tissue in a porcine model.34
Conclusions
A 1-cm R0 surgical margin width has been traditionally consid-
ered necessary to avoid local intrahepatic recurrence and optimize
longterm survival after hepatic resection for CLM. Recently, more
rigorous multi-institutional data have reported that the likelihood
of local recurrence is independent of margin width. Rather than
millimetres, tumour biology is a more important predictor of
both intrahepatic any-site recurrence and worse overall survival.
Although an R1 resection should clearly be avoided, the actual
margin width of an R0 resection does not impact on outcome
after resection of CLM. Data have shown that CLM are over-
whelmingly well circumscribed and are associated with very low
incidences of satellitosis or micro-metastasis. Surgeons should
employ a systematic approach, which should include high-quality
preoperative cross-sectional imaging as well as the use of intraop-
erative ultrasonography. Although surgeons should not strive to
achieve a ‘minimal margin’, a limited negative margin resection in
patients with hepatic CRM does not seem to affect survival, local
recurrence risk or site of recurrence. As such, failure to comply
with the 1-cm rule can no longer be considered a contraindication
for the surgical resection of CLM.
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